Literature DB >> 25161044

Omega-6 fatty acids and cardiovascular disease: friend, not foe?

William S Harris1, Gregory C Shearer2.   

Abstract

Entities:  

Keywords:  Editorials; cardiovascular diseases; epidemiology; fatty acids; prostaglandins

Mesh：

Substances：

Year:  2014        PMID： 25161044     DOI： 10.1161/CIRCULATIONAHA.114.012534

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  25 in total

1.  Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver.

Authors:  Swapnil V Shewale; Elena Boudyguina; Xuewei Zhu; Lulu Shen; Patrick M Hutchins; Robert M Barkley; Robert C Murphy; John S Parks
Journal:  J Lipid Res       Date:  2015-04-28       Impact factor: 5.922

Review 2.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

3.  In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.

Authors:  Swapnil V Shewale; Amanda L Brown; Xin Bi; Elena Boudyguina; Janet K Sawyer; Martha A Alexander-Miller; John S Parks
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

4.  The effects of fatty acid composition on cardiac hypertrophy and function in mouse models of diet-induced obesity.

Authors:  Son Nguyen; Dan Shao; Loreta C Tomasi; Alyssa Braun; Ana Barbosa Marcondes de Mattos; Yong Seon Choi; Outi Villet; Nathan Roe; Carliana R Halterman; Rong Tian; Stephen C Kolwicz
Journal:  J Nutr Biochem       Date:  2017-05-25       Impact factor: 6.048

Review 5.  Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.

Authors:  Timothy D O'Connell; Katherine A Murphy; Naixin Zhang; Sara J Puccini; Chastity L Healy; Brian A Harsch; Michael J Zhang; Gregory C Shearer
Journal:  Physiology (Bethesda)       Date:  2022-08-09

6.  Plasma fatty acids, oxylipins, and risk of myocardial infarction: the Singapore Chinese Health Study.

Authors:  Ye Sun; Hiromi W L Koh; Hyungwon Choi; Woon-Puay Koh; Jian-Min Yuan; John W Newman; Jin Su; Jinling Fang; Choon Nam Ong; Rob M van Dam
Journal:  J Lipid Res       Date:  2016-05-24       Impact factor: 5.922

7.  A genome-wide association study of n-3 and n-6 plasma fatty acids in a Singaporean Chinese population.

Authors:  Rajkumar Dorajoo; Ye Sun; Yi Han; Tingjing Ke; Ayala Burger; Xuling Chang; Hui Qi Low; Weihua Guan; Rozenn N Lemaitre; Chiea-Chuen Khor; Jian-Min Yuan; Woon-Puay Koh; Choon Nam Ong; E Shyong Tai; Jianjun Liu; Rob M van Dam; Chew-Kiat Heng; Yechiel Friedlander
Journal:  Genes Nutr       Date:  2015-11-19       Impact factor: 5.523

8.  Gut Microbiota and Host Plasma Metabolites in Association with Blood Pressure in Chinese Adults.

Authors:  Bing Zhang; Penny Gordon-Larsen; Yiqing Wang; Huijun Wang; Annie Green Howard; Matthew C B Tsilimigras; Christy L Avery; Katie A Meyer; Wei Sha; Shan Sun; Jiguo Zhang; Chang Su; Zhihong Wang; Anthony A Fodor
Journal:  Hypertension       Date:  2020-12-21       Impact factor: 10.190

Review 9.  Omega-3 fatty acids for breast cancer prevention and survivorship.

Authors:  Carol J Fabian; Bruce F Kimler; Stephen D Hursting
Journal:  Breast Cancer Res       Date:  2015-05-04       Impact factor: 6.466

Review 10.  Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence.

Authors:  Karsten H Weylandt; Simona Serini; Yong Q Chen; Hui-Min Su; Kyu Lim; Achille Cittadini; Gabriella Calviello
Journal:  Biomed Res Int       Date:  2015-08-02       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.